What Is LDL Cholesterol? Normal vs Optimal Range Explained

Standard LDL-C testing measures the cholesterol mass carried by LDL particles, but atherosclerosis is driven by the number of particles penetrating artery walls—not the amount of cholesterol each one carries. The CTD maps over 3,600 compound interactions affecting LDL metabolism and cholesterol transport pathways. Two people with identical LDL-C of 120 mg/dL can have vastly different cardiovascular risk: one may have fewer large, buoyant LDL particles (lower risk), while another has many small, dense particles (much higher risk). This discordance between LDL-C and actual particle count is why approximately half of all heart attacks occur in people with normal LDL cholesterol. ApoB—which directly measures the number of atherogenic particles—resolves this limitation, making it the preferred cardiovascular risk marker in updated European and Canadian guidelines.

The push to lower LDL indefinitely also has a physiological floor. PubMed indexes over 220,000 publications on LDL cholesterol, with clinical analyses demonstrating that LDL below 50 mg/dL is associated with impaired steroid hormone synthesis (cholesterol is the precursor for cortisol, testosterone, estrogen, and progesterone), increased risk of hemorrhagic stroke, depression, and cognitive changes in some populations. Cholesterol is not simply a cardiovascular villain—it is an essential structural component of every cell membrane, the raw material for bile acid and vitamin D production, and the substrate for all steroid hormones. The optimal range of 60–100 mg/dL balances genuine cardiovascular protection with biological necessity, recognizing that aggressive LDL lowering below 50 trades one set of risks for another.

Several common medical conditions alter LDL-C independently of diet and lifestyle. FAERS data document LDL changes across over 300 medication entries, spanning statins, PCSK9 inhibitors, corticosteroids, antipsychotics, and hormonal therapies. Hypothyroidism is the most frequently missed reversible cause of elevated LDL—thyroid hormone drives LDL receptor expression, so untreated hypothyroidism reduces hepatic LDL clearance and raises blood levels. Checking TSH before starting statin therapy can identify patients whose elevated LDL will normalize with thyroid hormone replacement alone. Insulin resistance produces a characteristically atherogenic lipid pattern: elevated triglycerides, low HDL, and small dense LDL particles that are poorly captured by standard LDL-C testing. In this metabolic pattern, ApoB and triglyceride-to-HDL ratio are far more informative than LDL-C alone.